The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease

AbstractVitamin D receptor (VDR) polymorphisms were indicated to be associated with coronary artery disease (CAD); however, published studies reported inconsistent results.The aim of this meta-analysis is to reach a more accurate estimation of the relationship between VDR genetic polymorphisms and CAD risk.Eligible studies were retrieved by searching PubMed, Embase, VIP, Wanfang and China National Knowledge Infrastructure databases. Included and excluded criteria were formulated. The case group was patients with CAD, and the control group was healthy subjects. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate VDR polymorphisms associations with CAD risk. Heterogeneity was evaluated by Q statistic and I2 statistic.Seven studies of a total of 2306 CAD patients and 4151 control subjects met the inclusion criteria. The pooled results from Taq1 showed increased risk in allelic model (OR = 1.14, 95% CI = 1.02–1.28), dominant model (OR = 1.21, 95% CI = 1.02–1.43), heterozygote model (OR = 1.19, 95% CI = 1.00–1.1.42), and homozygote model (OR = 1.27, 95% CI = 1.01–1.61). Besides, Fok1 T > C showed decreased risk in allelic model (OR = 0.81, 95% CI = 0.65–1.00) and Fok1 A > G also showed decreased risk in allelic model (OR = 0.67, 95% CI = 0.45–1.00) and recessive model (OR = 0.55, 95% CI = 0.31–0.97). In Caucasian subgroup, Bsm1showed increased risk in allelic model (OR = 1.23, 95% CI = 1.02–1.47), heterozygote model (OR = 1.20, 95% CI = 1.00–1.44), and homozygote model (OR = 1.22, 95% CI = 1.02–1.45). In CAD patients with type 2 diabetes mellitus (T2DM), Apa1showed a decreased risk in heterozygote model (OR = 0.80, 95% CI = 0.66–0.98); however, increased risk in recessive model (OR = 5.00, 95% CI = 2.74–9.13) was discovered in CAD patients without T2DM.The Fok1 polymorphism may play a protective role in CAD, and the possible protective role in Apa1 CA genotype in CAD patients with T2DM needs further studies. The Taq1 polymorphism is found to be associated with a significant increase in CAD risk based on our analysis; moreover, increased risk in Apa1 polymorphism in CAD patients without T2DM and Bsm1 polymorphism in Caucasian group is also detected.

[1]  Ruth McPherson,et al.  Genetics of Coronary Artery Disease. , 2016, Circulation research.

[2]  B. Wożakowska-Kapłon,et al.  Clinical and angiographic characteristics of coronary artery disease in young adults: a single centre study. , 2015, Kardiologia polska.

[3]  Jia Jiang,et al.  Steroid Injection and Nonsteroidal Anti-inflammatory Agents for Shoulder Pain , 2015, Medicine.

[4]  M. Gad,et al.  Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence , 2015, Journal of receptor and signal transduction research.

[5]  Sonia S Anand,et al.  Cardiovascular Disease in South Asian Migrants. , 2015, The Canadian journal of cardiology.

[6]  Hongwei Shan,et al.  Associations between Lectin-like, oxidized low-density lipoprotein receptor-1 G501C and 3'-UTR-C188T polymorphisms with coronary artery disease: a meta-analysis. , 2015, International journal of clinical and experimental medicine.

[7]  Yijiang Zhou,et al.  Association of two polymorphisms in the FADS1/FADS2 gene cluster and the risk of coronary artery disease and ischemic stroke. , 2015, International journal of clinical and experimental pathology.

[8]  M. Bęćkowski,et al.  Acute coronary syndromes in young women – the scale of the problem and the associated risks , 2015, Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery.

[9]  Menghong Wang,et al.  Association of vitamin d receptor-a gene polymorphisms with coronary heart disease in Han Chinese. , 2015, International journal of clinical and experimental medicine.

[10]  J. Armendáriz-Borunda,et al.  Vitamin-D receptor gene polymorphisms (TaqI and ApaI) and circulating osteocalcin in type 2 diabetic patients and healthy subjects. , 2015, Endokrynologia Polska.

[11]  R. Wu,et al.  Vitamin D receptor genetic variants and Parkinson's disease in a Taiwanese population , 2014, Neurobiology of Aging.

[12]  K. Mirzaei,et al.  The Role of Vitamin D Deficiency and Vitamin D Receptor Genotypes on the Degree of Collateralization in Patients with Suspected Coronary Artery Disease , 2014, BioMed research international.

[13]  W. Yeh,et al.  Antineuroinflammatory effects of lycopene via activation of adenosine monophosphate-activated protein kinase-α1/heme oxygenase-1 pathways , 2014, Neurobiology of Aging.

[14]  M. Holick,et al.  Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.

[15]  M. Marre,et al.  Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. , 2013, Diabetes & metabolism.

[16]  J. Jerrell,et al.  Population-Based Treated Prevalence of Congenital Heart Disease in a Pediatric Cohort , 2013, Pediatric Cardiology.

[17]  F. Jakob,et al.  1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity , 2012, PloS one.

[18]  Y. Li.  Molecular Mechanism of Vitamin D in the Cardiovascular System , 2011, Journal of Investigative Medicine.

[19]  J. Hokanson,et al.  Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes , 2011, Diabetes Care.

[20]  Keith C. Norris,et al.  1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  A. Uitterlinden,et al.  Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention , 2010, Expert opinion on therapeutic targets.

[22]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[23]  Tian-Yi Chen,et al.  No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. , 2009, DNA and cell biology.

[24]  K. Badenhoop,et al.  Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  R. D'Agostino,et al.  Genetic and non-genetic correlates of vitamins K and D , 2009, European Journal of Clinical Nutrition.

[26]  Chunbo Tang,et al.  Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis , 2009, Breast Cancer Research and Treatment.

[27]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[28]  T. Assimes,et al.  A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. , 2008, Atherosclerosis.

[29]  D. Tishkoff,et al.  1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  Jiang He,et al.  Major causes of death among men and women in China. , 2005, The New England journal of medicine.

[31]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[32]  N. Swamy,et al.  Anti-endothelial properties of 1,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of calcitriol , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  K. Zerres,et al.  Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large‐scale angiographic cohort of 3441 patients , 2003, European journal of clinical investigation.

[34]  J. Liao,et al.  1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. , 2002, Circulation research.

[35]  R. Hoffmann,et al.  The vitamin D receptor gene variant is associated with the prevalence of Type 2 diabetes mellitus and coronary artery disease , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[36]  T. Spector,et al.  Genetic Contribution to Bone Metabolism, Calcium Excretion, and Vitamin D and Parathyroid Hormone Regulation , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  A J Sutton,et al.  Publication and related biases. , 2000, Health technology assessment.

[38]  S. Golder,et al.  The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. , 2000, Health technology assessment.

[39]  J. Cauley,et al.  Molecular epidemiology of vitamin D receptor gene variants. , 2000, Epidemiologic reviews.

[40]  D. Bell,et al.  Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  G. Hitman,et al.  Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. , 1998, Diabetes.

[42]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.